14.10.2015 • News

Solvay Buys EPIC Polymers’ LFT Technology

Belgian chemical producer Solvay has acquired the long-fiber thermoplastics (LFT) technology of Germany’s EPIC Polymers to complement its offering of high performance light-weighting materials for the automotive industry. The privately owned Kaiserslautern-based firm is a leading supplier of high strength thermoplastics, tribologically optimized thermoplastics and conductive thermoplastics. Its new technology enables the reinforcement of high performance thermoplastic polymers with long glass fibers to make semi-structural parts replacing metal components in automobile exteriors.

Solvay said the sophisticated materials, in demand from automakers aiming to reduce fuel consumption, offer superior mechanical and thermal properties, coupled with high impact resistance, strength and stiffness at elevated temperatures. In addition to PEEK and PAEK polymers, the company will use the LFT technology in its Amodel PPA and Ryton PPS portfolio of products as well as in its Technyl range of PA 6.6.

Solvay Specialty Polymers already manufactures products that can replace metal in such demanding automotive under-the-hood components as hot air ducts, powertrains, engine control units, oil and water modules and conduits. These will be complemented in future by the LFT-based products for exterior applications.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read